source
- Lycia Therapeutics files for IPO to fund antibody degrader platformLycia Therapeutics, a protein‑degradation startup built on research from Nobel laureate Carolyn Bertozzi, announced it has filed for an initial public offering. The filing is intended to raise cap…
- BioSpace honors 40 emerging leaders shaping biopharma with breakthroughs in mRNA, gene and cell therapiesBioSpace announced its latest 40 Under 40 cohort, recognizing young professionals who have made notable contributions across biopharma. The honorees span a range of roles, from scientific innovator…